OncoSec Medical, Inc.
(NASDAQ : ONCS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
PROGProgenity, Inc. 18.40%2.960.0%$356.96m
GHGuardant Health, Inc. -0.16%109.350.0%$124.52m
SDCSmileDirectClub, Inc. -7.23%5.390.0%$85.75m
DVADaVita, Inc. 0.12%115.553.7%$77.62m
AMEDAmedisys, Inc. 1.32%169.3811.4%$75.17m
OSHOak Street Health, Inc. 0.99%46.910.0%$69.79m
NTRANatera, Inc. 2.32%114.931.1%$56.84m
NEONeoGenomics, Inc. 0.18%44.895.1%$54.36m
NVTAInvitae Corp. -0.82%27.991.1%$51.76m
LHCGLHC Group, Inc. -2.30%145.622.9%$47.83m
CHEChemed Corp. -2.26%450.6310.2%$45.46m
ONEM1Life Healthcare, Inc. 0.23%21.940.0%$44.30m
AGLAgilon Health, Inc. -3.07%23.710.0%$39.76m
FLGTFulgent Genetics, Inc. -0.90%84.060.6%$35.91m
CANOCano Health, Inc. -1.73%11.910.0%$33.91m

Company Profile

OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.